Long-term outcomes of non-metastatic breast cancer patients by molecular subtypes

被引:0
作者
Afsaneh Fendereski
Ebrahim Hajizadeh
Shahpar Haghighat
Aliakbar Rasekhi
机构
[1] Tarbiat Modares University,Department of Biostatistics, Faculty of Medical Sciences
[2] Motamed Cancer Institute,Breast Cancer Research Center
[3] ACECR,undefined
来源
BMC Women's Health | / 22卷
关键词
Breast cancer; Molecular subtypes; Disease-free survival; Mixture cure model;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 162 条
[1]  
Miller KD(2018)Cancer statistics for Hispanics/Latinos, 2018 CA: Cancer J Clin 68 425-445
[2]  
Goding Sauer A(2021)Cancer in Iran 2008 to 2025: recent incidence trends and short-term predictions of the future burden Int J Cancer 149 594-605
[3]  
Ortiz AP(2019)Breast cancer among young women in Iran Int J Women’s Health Reprod Sci 7 1-15
[4]  
Fedewa SA(2017)Breast cancer status in Iran: statistical analysis of 3010 cases between 1998 and 2014 Int J Breast Cancer. 2017 1-10
[5]  
Pinheiro PS(2000)Molecular portraits of human breast tumours Nature 406 747-752
[6]  
Tortolero-Luna G(2012)Comprehensive molecular portraits of human breast tumours Nature 490 61-70
[7]  
Roshandel G(2014)US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status JNCI J Natl Cancer Inst. 106 dju055-125
[8]  
Ferlay J(2014)Biological subtypes of breast cancer: prognostic and therapeutic implications World J Clin Oncol 5 412-198
[9]  
Ghanbari-Motlagh A(2020)Behavior of metastatic breast cancer according to subtype Breast Cancer Res Treat 181 115-5528
[10]  
Partovipour E(2020)A population-based analysis of breast cancer incidence and survival by subtype in Ontario women Curr Oncol 27 191-3588